Study of the Proteome and Cytokines During Inflammatory Syndromes of Different Etiologies.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

97 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2012-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The hypotheses of our research are based on the fact that various pathological states, infection, cancer, inflammatory disease, can induce an inflammatory syndrome, through different pathways, even though the clinical presentation can be identical. The identification of biological markers specific to an etiology would therefore allow a faster diagnosis and improve care for patients. We thus took an interest in the three groups of diseases most frequently responsible for an inflammatory syndrome, infections, cancers and auto-immune diseases. To achieve this, various methods will be used.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases

NCT02839278

Inflammation

COMPLETED NA

Transcriptomic Profiling in Severely Injured Patients

NCT02508272

Trauma Inflammation Sepsis

COMPLETED

Inflammation and the Host Response to Injury (Burns)

NCT00257244

Trauma Burns Multiple Organ Failure

COMPLETED

Inflammation and the Host Response to Injury (Trauma)

NCT00257231

Trauma Burns Multiple Organ Failure

COMPLETED

Differences in Genes and Proteins in Active and Controlled Uveitis

NCT00357266

Ocular Inflammatory Disease Uveitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with inflammatory syndrome

Group Type OTHER

proteomic analysis

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

proteomic analysis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients presenting an inflammatory syndrome, defined by elevated C-reactive protein (CRP\>50mg/L), whose etiology is related to infection, cancer or an inflammatory disease.

* Patients not on treatment (corticoids, immunosuppressive drugs) during the 7 days preceding inclusion
* Age: 18-90 years
* Patients covered by the National Health Insurance Agency
* signed written informed consent form

* Pregnant patients

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No